Literature DB >> 3182092

Concentrations of roxithromycin (RU 28965) in serum and in sinus mucosa.

A Kropec, E Schmidt-Eisenlohr, F D Daschner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3182092     DOI: 10.1007/bf01650767

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  7 in total

1.  In-vitro activity of RU 28965, a new macrolide, compared to that of erythromycin.

Authors:  K V Rolston; B LeBlanc; D H Ho
Journal:  J Antimicrob Chemother       Date:  1986-02       Impact factor: 5.790

2.  [RU 28965, a new semi-synthetic macrolide. Bioavailability and pharmacokinetic profile after oral administration].

Authors:  D Tremblay; A Bryskier; M Vuckovic; A Stockis; C Manuel
Journal:  Pathol Biol (Paris)       Date:  1985-06

Review 3.  Comparative pharmacokinetics of macrolides.

Authors:  O G Nilsen
Journal:  J Antimicrob Chemother       Date:  1987-11       Impact factor: 5.790

4.  Roxithromycin (RU 28965) in the treatment of respiratory tract infections.

Authors:  C Grassi; R Bertoletti; V De Rose; G Manara; P Mangiarotti
Journal:  Chemioterapia       Date:  1987-02

5.  Antibacterial activity of roxithromycin: a laboratory evaluation.

Authors:  J F Chantot; A Bryskier; J C Gasc
Journal:  J Antibiot (Tokyo)       Date:  1986-05       Impact factor: 2.649

6.  Pharmacokinetics and tissue penetration of roxithromycin after multiple dosing.

Authors:  R Wise; B Kirkpatrick; J Ashby; J M Andrews
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

7.  In vitro activity of the new macrolide antibiotic roxithromycin (RU 28965) against clinical isolates of Haemophilus influenzae.

Authors:  J H Jorgensen; J S Redding; A W Howell
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

  7 in total
  2 in total

Review 1.  Formulary management of macrolide antibiotics.

Authors:  D R Guay
Journal:  Pharmacoeconomics       Date:  1995-12       Impact factor: 4.981

Review 2.  Macrolide antibiotics in paediatric infectious diseases.

Authors:  D R Guay
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.